(Box) Status BTA Rapid Test Kit CLIA Waived, 25/Bx

A Rapid Test For the Qualitative Detection of Bladder Tumor Associated Antigen
in Human Urine

Features and Benefits:

• CLIA Waived
• Indicated for the use as an aid in the monitoring of bladder cancer patients in conjunction with cystoscopy
• Simple procedure
• Accurate test results with superior sensitivity and specificity
  

Status BTA Rapid Test Kit – CLIA Waived Bladder Cancer Monitoring

The Status BTA Rapid Test Kit is a CLIA-waived qualitative test designed to detect Bladder Tumor Associated Antigen in human urine. Indicated as an aid in monitoring bladder cancer patients alongside cystoscopy, this test delivers accurate results with superior sensitivity and specificity using a simple, straightforward procedure.

Key Features

• CLIA Waived – ready for clinical use in waived laboratories
• High sensitivity and specificity for reliable monitoring
• Simple, quick procedure requiring minimal training
• Supports bladder cancer patient surveillance protocols

Ideal For

Urology clinics, hospital laboratories, and healthcare facilities managing bladder cancer patients. Available in boxes of 25 tests, this product is suitable for multi-location healthcare systems and bulk purchasing.

Bulk & Distributor Pricing

Big Ben Medical Supplies offers competitive pricing for healthcare facilities, clinics, and distributors across North America. Contact your sales representative for volume discounts and multi-location pricing.

Product Documentation

• Status BTA Sales Brochure
• Status BTA Package Insert
• Status BTA Patient Instructions
• BTA Control SDS

Shipping & Availability

Typically ships within 5–10 business days. Back-ordered items are fulfilled directly from the manufacturer and may require additional time. For precise shipping timelines and delivery details, contact your sales representative.